News & Insights

  • 23/05/2019
  • News

Van Bael & Bellis launches the sixth edition of its “EU Anti-Dumping and Other Trade Defence Instruments"

The definitive book on EU trade defence law appears in a fully updated sixth edition. As comprehensive in its coverage as its predecessors, this new edition of the Van Bael & Bellis book on “EU Anti-Dumping and Other Trade Defence Instruments” provides incisive analysis and critical commentary on all relevant aspects of the EU trade defence instruments as actually applied by the EU Institutions against the backdrop of WTO law. The book covers every issue likely to arise in any trade defence matter and examines the numerous cases decided under the EU anti-dumping, countervailing, safeguard and trade barriers regulations, including all of the following and more: • determining the dumping and injury margins; • rules for the determination of permissible adjustments; • clarification of the terms ‘significant distortions’ and ‘distortions on raw materials’; • determining the subsidy margin; • determining the causal link between dumping or subsidy and injury; • determining if “Union interest” calls for intervention; • examining the differences between anti-dumping and anti-subsidy legislation; • procedural rules applicable to complaints, initiation of proceedings, investigations, protective measures, reviews and refunds; • conditions for accepting an undertaking; • measures that may be taken to prevent ‘circumvention’ of anti-dumping or countervailing measures; • rules governing the standing of various interested parties before the European Courts; • allocation and administration of quantitative quotas; and • surveillance measures. As a detailed and practical commentary on the relevant aspects of the EU trade defence instruments as actually applied by the EU institutions in the light of WTO law, the sixth edition of this book remains without peer as a guide to EU trade defence law. To order a copy of the book from Kluwer, click on this link.

Read more
    • 04/06/2020
    • Articles

    Covid-19 Special Alert │ 04 June 2020

    The VBB Alert covers Covid-19 related aspects of competition law at both the European Union and Member State levels, with a special focus on state aid measures in Belgium, France, Germany, Italy, Luxembourg, the Netherlands and the UK.

    Download PDF
    • 04/06/2020
    • Articles

    Europe - Four-Country Inclusive Vaccine Alliance In Quest for Covid-19 Vaccine

    In a letter to Parliament and a press release (see, attachments), the Dutch Minister for Public Health, Wellbeing and Sports, Hugo de Jonge, revealed on 3 June 2020 an initiative of Italy, France, Germany and The Netherlands to work together to secure a Covid-19 vaccine for “the European Union and other countries”.   According to the Minister, the “Inclusive Vaccine Alliance” (IVA) is in talks with several pharmaceutical companies regarding promising ventures and in the process hopes to establish a European manufacturing base for the vaccine. The IVA’s ultimate goal is to create a medicine that is “accessible, available and affordable”.   Other countries will be given the opportunity to join the IVA which is also in contact with the European Commission.

    Download PDF
    • 03/06/2020
    • Articles

    European Commission Publishes Roadmap Towards Pharmaceutical Strategy for Europe

    The European Commission (the Commission) published on 2 June 2020 its roadmap towards a Pharmaceutical Strategy for Europe (PSE) which it plans to publish in the fourth quarter of 2020 (see, attachment). The roadmap defines the steps which the Commission will take prior to adopting the PSE and the data which it will assemble to inform its PSE. While the Commission will consult a range of stakeholders, it has already announced a public consultation which will run until 7 July 2020.

    Download PDF
    • 02/06/2020
    • Articles

    Italian Competition Authority Approves Scheme for Distribution of Surgical Masks

    On 1 June 2020, the Italian competition authority (“L’Autorità Garante della Concorrenza e del Mercato”) authorised a scheme that would allow disposable surgical masks to be distributed and sold in pharmacies and health product retail outlets (see, attached press release). It did so at the request of the two principal Italian associations of pharmaceutical wholesalers. Under the scheme, the wholesalers and associations of pharmacists and health product retailers acquire the masks in a joint procurement procedure. The masks are then allocated among the wholesalers at a uniform price per unit that was agreed upon with the suppliers. The scheme will last until 30 June 2020. The competition authority approved the scheme because it solves an urgent and wide-ranging health problem and is limited in time. It thus applied for the first time the principles of its guidance of 22 April 2020 regarding cooperation agreements designed to ensure the distribution of scarce essential goods and services, including health products and food. The competition authority’s approach is in line with the views expressed by the European Commission and competition authorities around Europe to address the problems resulting from the Covid-19 pandemic (see e.g., Van Bael & Bellis Life Sciences News Alert of 9 April 2020 and of 26 May 2020). Not coincidentally, the competition authority indicates that it obtained counsel from the European Commission.

    Download PDF
    • 29/05/2020
    • Articles

    European Commission Presents EU4Health Programme

    On 28 May 2020 the European Commission (the Commission) presented details of its new, stand-alone EU4Health Programme, a proposal to commit considerable EU resources to health during the 2021-2027 period (EU4Health). The budget which the Commission proposes to earmark for EU4Health, EUR 9.4 billion, reflects a more than 20-fold increase over the funds previously dedicated to this policy area (EUR 413 million). The Commission first made its plan public as part of the presentation of ‘Next Generation EU’, a EURO 750 billion recovery plan to be embedded in and added to the long term overall EU budget for the 2021-2027 period (see, Van Bael & Bellis Life Sciences News Alert, 28 May 2020).

    Download PDF
    • 28/05/2020
    • Newsletters

    VBB on Competition Law, Volume 2020, No. 5

    The May 2020 issue of our newsletter, VBB on Competition Law, which covers major developments in competition law at both the European Union and Member State levels.

    Download PDF
    • 28/05/2020
    • Articles

    Next Generation EU - European Commission Proposes Significant Funding and Expanded EU Health Programme

    The European Commission (the Commission) published on 27 May 2020 its proposal for a major recovery plan and put forward a new EUR 750 billion recovery instrument called ‘Next Generation EU’ that would be embedded in and added to the long term EU budget (itself worth some EUR 1,100 billion between 2021 and 2027). The money from Next Generation EU would be available to the Member States in the form of both grants (EUR 500 billion) and loans (EUR 250 billion). The focus of the recovery plan is the green and digital transition but the plan also has a substantial health component, at times intertwined with green and digital aspects.

    Download PDF
    • 26/05/2020
    • Articles

    Dutch Competition Authority Supports Cooperation in Distributing Essential Medicines

    The Dutch competition authority, Autoriteit Consument en Markt (ACM), published a statement indicating that it supports the cooperation between hospitals, hospital pharmacies and pharmaceutical wholesalers to reduce or avert shortages of 14 essential medicines for which demand during the Covid-19 crisis has soared (see, attachment). ACM took the position in response to a request made by Landelijk Coördinatiecentrum Geneesmiddelen (LCG), an organisation established in April 2020 to secure supplies of medicines for intensive care treatment and surgery in hospitals. LCG organises the procurement and distribution of these medicines. ACM said that it did not expect any competition problems to arise. It explained that this form of cooperation was transparent, temporary and necessary to prevent both national and local medicine shortages. It added that the measures adopted by LCG did not extend beyond what is necessary to achieve this goal. ACM also pointed out that safeguards had been put in place to avoid the exchange of information among wholesalers regarding prices or stocks. The ACM’s position is in line with that taken by other competition authorities around Europe to make sure that supplies of essential goods such as medicines and foodstuffs would not be curtailed (see e.g., Van Bael & Bellis Life Sciences News Alerts of 9 April 2020 and 29 April 2020).

    Download PDF
    • 22/05/2020
    • News

    Andrzej Kmiecik participates in ICC-Baker McKenzie 14th Annual Conference on Trends and Developments in Global Competition Law

    On 15 May 2020, Van Bael & Bellis partner and head of competition Andrzej Kmiecik participated in a panel discussing developments in international merger control at the 14th Annual Conference on Trends and Developments in Global Competition Law organised online by the London-based Interdisciplinary Centre for Competition Law and Policy and Baker McKenzie. Other members of the panel were: Chris Prevett, Senior Legal Director, Mergers, Markets & Sector Regulation, UK Competition and Markets Authority and Heather Johnson, Senior Counsel to the Director, US Federal Trade Commission. The panel was chaired by Eyad Maher Dabbah, Director and Professor, ICC, Queen Mary University of London. Further information on the conference is available here.

    Read more

Showing 1-9 of 1220 insights

View more
Keep updated Sign up for VBB insights

Be the first amongst your peers to get the latest publications and insights.